Please login to the form below

Not currently logged in
Email:
Password:

UCB launches UK product helpline for patients and HCPs

UCBCares will answer treatment queries and use feedback to drive innovation
UCB

UBC has launched a new seven-day helpline for healthcare professionals and patients in the UK and Ireland who have questions about its products.

The service, called UCBCares, looks to close gaps between drug development and patient outcomes, working with the NHS and patients to develop innovative treatments that deliver the best care.

It will be run by scientists from its UK & Ireland headquarters and global immunology research centre in Slough, Berkshire who will answer queries and take feedback to drive 'patient-centric innovation'.

Steve Turley, managing director for UCB British and Irish Isles, said: “UBCCares is an important service for making sure that those taking or prescribing our treatments get the most out of them.

“Greater patient involvement in their own care has grown but this has been coupled with increased pressure on the NHS and so there is a natural role for industry to better support patients.

“UCBCares is just one way we are opening our doors so that we can achieve better outcomes for patients and design innovative new medicines for the patients of tomorrow.”

The launch of the UK service follows successful debuts of equivalent helplines in Germany and the US.

Article by
Rebecca Clifford

6th October 2016

From: Marketing, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics